Across TCGA pan-cancer cohorts, RNY3P9 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RNY3P9 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNY3P9 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNY3P9 expression acts as an unfavorable survival marker.

THCA, BRCA, and PCPG are the cancer types where RNY3P9 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.683	0.950	<.001	93	view →
BRCA	DFS	Tertile	III,IV	0.648	0.884	.006	51	view →
PCPG	OS	Tertile	All	0.010	0.946	<.001	36	view →
READ	DFS	Tertile	III,IV	0.027	0.761	<.001	36	view →
ACC	DFS	Tertile	II,III,IV	0.057	0.631	.002	27	view →
THYM	OS	Tertile	All	0.352	0.884	<.001	24	view →
LIHC	DFS	Tertile	All	0.092	0.530	.003	18	view →
LAML	DFS	Tertile	All	0.313	0.601	.026	18	view →
DLBC	DFS	Tertile	III,IV	0.137	0.790	<.001	18	view →
KIRC	DFS	Tertile	All	0.345	0.631	.038	12	view →
KIRP	OS	Tertile	II,III,IV	0.199	0.771	.030	9	view →
ESCA	DFS	Tertile	II,III,IV	0.335	0.538	.049	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

Exploration

Same gene, other analysis: RNY3P9 tumor-vs-normal RNA expression · all RNY3P9 data types